Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion
Journal of Neural Transmission · 31.10.2026
DOI: 10.1007/s00702-026-03301-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neural Transmission, online erschienen am 31.10.2026. Verfasst von Elena Contaldi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson Institute of Milan, ASST Gaetano Pini-CTO, via Emilio Bignami 1, Milan, 20126, Italy. Elena.Contaldi@asst-pini-cto.it. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Grigioni per il Morbo di Parkinson.
Abstract (Originalsprache)
Continuous subcutaneous foslevodopa/foscarbidopa infusion (LDp/CDp-CSI) is an effective treatment for patients with Parkinson’s disease (PD), but infusion-site nodules are a major cause of treatment discontinuation. Systemic inflammation can influence local skin tolerance; however, predictive biomarkers remain unidentified. To evaluate the predictive value of the neutrophil-to-lymphocyte ratio (NLR) for clinically significant infusion-site nodules (PD-CSN) during LDp/CDp-CSI and to establish a clinical management framework to mitigate their development. We prospectively followed 38 patients with PD initiating LDp/CDp-CSI for ≥ 3 months. Baseline immunological data were collected before infusion. A subset of 30 patients was followed for an average of 11 months to identify factors associated with skin nodules at longer follow-up. Nodules were classified by blinded raters. Between-group comparisons, ANCOVA, ROC curve, and Kaplan-Meier analyses were performed. At 3 months, 42% of patients were PD-CSN and showed higher baseline neutrophil counts ( P = 0.030) and NLR ( P = 0.007), with NLR remaining independently associated with nodule status (F = 7.06, P = 0.012). ROC analysis demonstrated acceptable discrimination (AUC = 0.73, P = 0.016). At last follow-up, lower baseline lymphocyte counts ( P = 0.002) and higher NLR ( P = 0.001) were observed in PD-CSN. High baseline NLR predicted earlier nodule onset ( P = 0.001). Despite frequent nodules, multidisciplinary team surveillance, including remote and in-person follow-up, limited treatment discontinuation to 5.3%. Baseline systemic inflammation, reflected by NLR, predicts both the onset and persistence of infusion-site nodules during LDp/CDp-CSI. NLR may serve as a clinically accessible biomarker for early risk stratification. Multidisciplinary surveillance facilitates timely nodule management and enhances treatment adherence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parkinson Institute of Milan, ASST Gaetano Pini-CTO, via Emilio Bignami 1, Milan, 20126, Italy. Elena.Contaldi@asst-pini-cto.it.
- Parkinson Institute of Milan, ASST Gaetano Pini-CTO, via Emilio Bignami 1, Milan, 20126, Italy.
- Hospital Pharmacy Department, ASST G. Pini-CTO, Milan, Italy.
- Medical Management Unit, ASST G. Pini-CTO, Milan, Italy.
- Pezzoli Foundation for Parkinson's Disease, Milan, Italy.
- Parkinson Institute of Milan, ASST Gaetano Pini-CTO, via Emilio Bignami 1, Milan, 20126, Italy. Ioannis.Isaias@asst-pini-cto.it.
Förderung
- Fondazione Grigioni per il Morbo di Parkinson
Zitieren
APA
Contaldi, E., Magistrelli, L., Piazza, S., Caniglia, A., Mainardi, E. A., Giametta, P., Pezzoli, G., Isaias, I. U., & Lazzeri, G. (2026). Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion. Journal of Neural Transmission. https://doi.org/10.1007/s00702-026-03301-1
Vancouver
Contaldi E, Magistrelli L, Piazza S, Caniglia A, Mainardi EA, Giametta P, et al. Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion. Journal of Neural Transmission. 2026. doi:10.1007/s00702-026-03301-1
BibTeX
@article{Contaldi2026,
author = {Contaldi, Elena and Magistrelli, Luca and Piazza, Silvia and Caniglia, Arturo and Mainardi, Ennio A and Giametta, Pasquale and Pezzoli, Gianni and Isaias, Ioannis U and Lazzeri, Giulia},
title = {Neutrophil-to-lymphocyte ratio predicts infusion-site skin nodules in Parkinson’s disease patients receiving foslevodopa/foscarbidopa subcutaneous infusion},
journal = {Journal of Neural Transmission},
year = {2026},
doi = {10.1007/s00702-026-03301-1}
}
EUVIMED